U.S. Seeks ‘Urgent’ Data on Covid Relapses After Using Pfizer’s Paxlovid Drug - Bloomberg

U.S. Seeks ‘Urgent’ Data on Covid Relapses After Using Pfizer’s Paxlovid Drug - Bloomberg: U.S. government researchers are planning studies of how often and why coronavirus levels rebound in some Covid patients who have completed a five-day course of treatment with Pfizer Inc.’s Paxlovid.